Publication | Closed Access

Schedule-Dependent Apoptosis in K-ras Mutant Non–Small-Cell Lung Cancer Cell Lines Treated with Docetaxel and Erlotinib: Rationale for Pharmacodynamic Separation

Schedule-dependent ApoptosisOncologyMedicineMetronomic TherapyPharmacodynamic SeparationCell DeathAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyLung Cancer